Pace Andrea, Pibiri Ivana, Piccionello Antonio Palumbo, Buscemi Silvestre, Vivona Nicolo, Barone Giampaolo
Dipartimento di Chimica Organica E. Paterno, Università degli Studi di Palermo, Viale delle Scienze, Parco d'Orleans II, Edificio 17, I-90128 Palermo, Italy.
J Org Chem. 2007 Sep 28;72(20):7656-66. doi: 10.1021/jo701306t. Epub 2007 Sep 7.
The experimental investigation of the base-catalyzed rearrangements of 3-acylamino-1,2,4-oxadiazoles evidenced a new reaction pathway which competes with the well-known ring-degenerate Boulton-Katritzky rearrangement (BKR). The new reaction consists of a one-atom side-chain rearrangement that is base-activated, occurs at a higher temperature than the BKR, and irreversibly leads to the corresponding 2-acylamino-1,3,4-oxadiazoles. An extensive DFT study is reported to elucidate the proposed reaction mechanism and to compare the three possible inherent routes: (i) the reversible three-atom side-chain ring-degenerate BKR, (ii) the ring contraction-ring expansion route (RCRE), and (iii) the one-atom side-chain rearrangement. The results of the computational investigation point out that the latter route is kinetically preferred over the RCRE and can be considered as the ground-state analogue of a previously proposed C(3)-N(2) migration-nucleophilic attack-cyclization (MNAC) photochemically activated pathway. The MNAC consists of the formation of a diazirine intermediate, involving the exocyclic nitrogen, that eventually evolves into a carbodiimide intermediate (migration); the latter undergoes a single intramolecular nucleophilic attack-cyclization step leading to the final 2-acylamino-1,3,4-oxadiazole.
对3-酰基氨基-1,2,4-恶二唑的碱催化重排反应进行的实验研究表明,存在一种新的反应途径,它与广为人知的环退化Boulton-Katritzky重排反应(BKR)相互竞争。这种新反应由一个单原子侧链重排组成,该重排由碱激活,发生温度高于BKR,并且不可逆地生成相应的2-酰基氨基-1,3,4-恶二唑。本文报道了一项广泛的密度泛函理论(DFT)研究,以阐明所提出的反应机理,并比较三种可能的内在途径:(i)可逆的三原子侧链环退化BKR,(ii)环收缩-环扩张途径(RCRE),以及(iii)单原子侧链重排。计算研究结果指出,后一种途径在动力学上比RCRE更有利,并且可以被视为先前提出的光化学激活的C(3)-N(2)迁移-亲核攻击-环化(MNAC)途径的基态类似物。MNAC包括形成一个涉及环外氮的二氮丙环中间体,该中间体最终演变成碳二亚胺中间体(迁移);后者经历一个单分子内亲核攻击-环化步骤,生成最终的2-酰基氨基-1,3,4-恶二唑。